Document Detail


PPAR-α transcriptional activity is required to combat doxorubicin-induced podocyte injury in mice.
MedLine Citation:
PMID:  21625258     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Immunosuppressants and inhibitors of the renin angiotensin system are major reagents to treat nephrotic syndrome but their clinical effects are not necessarily satisfactory. Injection of doxorubicin in several strains of mice causes nephrotic syndrome-like disorder. Zhou et al. report that PPAR-α expression is downregulated in murine doxorubicin nephropathy and a PPAR-α agonist, fenofibrate, partially ameliorates the disorder induced likely through stabilization of nephrin expression and suppression of apoptosis in podocytes, providing a new preventive strategy.
Authors:
Kiyoshi Mori; Masashi Mukoyama; Kazuwa Nakao
Related Documents :
20129888 - Robinow syndrome, cockayne syndrome, and pfeiffer syndrome: an overview of physical, ne...
21777938 - Effects of dioxin exposure in eisenia andrei: integration of biomarker data by an exper...
2408988 - Cerebro-hepato-renal (zellweger) syndrome, adrenoleukodystrophy, and refsum's disease: ...
20966748 - Immunodeficiency secondary to anticytokine autoantibodies.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Kidney international     Volume:  79     ISSN:  1523-1755     ISO Abbreviation:  Kidney Int.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0323470     Medline TA:  Kidney Int     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1274-6     Citation Subset:  IM    
Affiliation:
Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Strengths and weaknesses of renal markers as risk factors and surrogate markers.
Next Document:  Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumo...